BridgeBio Pharma, Inc. (BBIO)
81.05
-0.45
(-0.55%)
USD |
NASDAQ |
Aug 24, 16:00
80.04
-1.01
(-1.25%)
After-Hours: 20:00
BridgeBio Pharma 1 Year Total Returns (Daily) : 62.25% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 62.25% |
| August 20, 2026 | 69.68% |
| August 19, 2026 | 71.64% |
| August 18, 2026 | 69.28% |
| August 17, 2026 | 55.67% |
| August 14, 2026 | 56.04% |
| August 13, 2026 | 61.19% |
| August 12, 2026 | 70.79% |
| August 11, 2026 | 73.51% |
| August 10, 2026 | 81.77% |
| August 07, 2026 | 83.85% |
| August 06, 2026 | 84.78% |
| August 05, 2026 | 66.61% |
| August 04, 2026 | 71.87% |
| August 03, 2026 | 68.80% |
| July 31, 2026 | 69.43% |
| July 30, 2026 | 80.05% |
| July 29, 2026 | 80.35% |
| July 28, 2026 | 85.05% |
| July 27, 2026 | 81.68% |
| July 24, 2026 | 84.01% |
| July 23, 2026 | 79.54% |
| July 22, 2026 | 80.60% |
| July 21, 2026 | 79.63% |
| July 20, 2026 | 73.64% |
| Date | Value |
|---|---|
| July 17, 2026 | 74.11% |
| July 16, 2026 | 70.49% |
| July 15, 2026 | 76.00% |
| July 14, 2026 | 76.33% |
| July 13, 2026 | 78.78% |
| July 10, 2026 | 85.63% |
| July 09, 2026 | 96.11% |
| July 08, 2026 | 81.36% |
| July 07, 2026 | 79.10% |
| July 06, 2026 | 76.74% |
| July 02, 2026 | 80.22% |
| July 01, 2026 | 74.19% |
| June 30, 2026 | 72.49% |
| June 29, 2026 | 60.52% |
| June 26, 2026 | 55.67% |
| June 25, 2026 | 57.03% |
| June 24, 2026 | 56.04% |
| June 23, 2026 | 62.73% |
| June 22, 2026 | 65.16% |
| June 18, 2026 | 65.68% |
| June 17, 2026 | 68.18% |
| June 16, 2026 | 61.98% |
| June 15, 2026 | 70.94% |
| June 12, 2026 | 68.47% |
| June 11, 2026 | 72.98% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| Ionis Pharmaceuticals, Inc. | 38.18% |
| Pfizer Inc. | 16.73% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| BioMarin Pharmaceutical, Inc. | 14.86% |